2348 Share Price

Open 4.57 Change Price %
High 4.60 1 Day 0.00 0.00
Low 4.55 1 Week -0.10 -2.13
Close 4.60 1 Month -0.12 -2.54
Volume 272000 1 Year -1.40 -23.33
52 Week High 6.94
52 Week Low 4.42
2348 Important Levels
Resistance 2 4.65
Resistance 1 4.63
Pivot 4.58
Support 1 4.57
Support 2 4.55
HKG HongKong Most Active Stocks
2324 0.06 20.00%
0261 0.01 0.00%
0566 3.91 0.00%
0997 0.04 0.00%
1398 4.85 0.00%
3988 3.60 0.00%
2233 0.89 8.54%
0981 1.03 0.00%
0939 5.88 -0.17%
1051 0.15 7.14%
More..
HKG HongKong Top Gainers Stocks
0711 1.07 50.70%
1137 1.64 33.33%
0524 0.57 23.91%
2324 0.06 20.00%
8286 0.66 15.79%
0559 0.40 14.29%
8155 0.08 14.29%
8106 0.65 14.04%
8249 0.65 14.04%
1039 1.80 12.50%
More..
HKG HongKong Top Losers Stocks
4333 60.00 -25.00%
1176 0.79 -20.20%
8046 0.05 -16.67%
8002 4.00 -15.97%
0607 2.71 -15.05%
8088 0.12 -14.29%
0660 0.08 -11.11%
0200 11.22 -10.38%
8262 1.83 -10.29%
0685 1.16 -10.08%
More..

Dawnrays Pharmaceutical (HKG: 2348)

2348 Technical Analysis 4
As on 9th Dec 2016 2348 Share Price closed @ 4.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.46 & Sell for SHORT-TERM with Stoploss of 4.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
2348 Target for December
1st Target up-side 5.04
2nd Target up-side 5.25
3rd Target up-side 5.46
1st Target down-side 4.44
2nd Target down-side 4.23
3rd Target down-side 4.02
2348 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.dawnrays.com
2348 Address
2348
CNT Tower
Units 3001-02
Wanchai,
Hong Kong
2348 Latest News
Interactive Technical Analysis Chart Dawnrays Pharmaceutical ( 2348 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dawnrays Pharmaceutical
2348 Business Profile
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China, India, and other countries. The company operates in two segments, Intermediates and Bulk Medicines, and Finished Drug. It offers cephalosporin antibiotics cover intermediates, bulk medicines, and powder for injections; and specific medicines covering therapeutic areas for anti-HBV, anti-allergic, cardiovascular system, digestive system, urinary system, and endocrine system with dosage forms of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wanchai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.